(Q36441010)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Raymonde Bouvier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sylvie Négrier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Lionel Badet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Denis Lyonnet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Oncology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

200-213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Prognostic factors of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Multi-institutional validation of a symptom based classification for renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Current staging of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Renal cell carcinoma: long-term survival and late recurrence

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Renal sinus involvement in renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Collecting system invasion in renal cell carcinoma: impact on prognosis and future staging strategies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Grading of renal cell carcinoma: Workgroup No. 2. Union Internationale Contre le Cancer and the American Joint Committee on Cancer (AJCC).

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Role of volume weighted mean nuclear volume for predicting disease outcome in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Value of morphometry as an independent prognostic factor in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Subtypes of renal cell carcinoma. Different onset and sites of metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Improved prognostication of renal cell carcinoma using an integrated staging system

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Paraneoplastic Signs and Symptoms of Renal Cell Carcinoma: Implications for Prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Gene expression profiling in breast cancer: towards individualising patient management

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Bias as a threat to the validity of cancer molecular-marker research

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

ALLELIC LOSS ON CHROMOSOMES 8 AND 9 CORRELATES WITH CLINICAL OUTCOME IN LOCALLY ADVANCED CLEAR CELL CARCINOMA OF THE KIDNEY

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Using protein expressions to predict survival in clear cell renal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Searching for the hereditary causes of renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behavior

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

CD70: a new tumor specific biomarker for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Distant metastasis of renal adenocarcinoma in nephrectomized cases.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

The treatment of renal cell carcinoma with solitary metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Results of surgical treatment of renal cell carcinoma with solitary metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Histologic characteristics of renal cell carcinomas with lymph node metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Partial nephrectomy for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Surgery for metastases of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Skeletal Metastases in 102 Patients Evaluated Before Surgery for Renal Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Low incidence of asymptomatic brain metastases in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Molecular imaging of antiangiogenic agents.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Imaging vascular physiology to monitor cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0479

7 January 2021

Identifiers

DOI

10.1038/NCPONC0479

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16596144%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference